首页 | 本学科首页   官方微博 | 高级检索  
     

支气管哮喘患者外周血中的CD+4 CD+25 T淋巴细胞的测定
引用本文:覃寿明,施焕中,覃雪军,陈一强,钟小宁. 支气管哮喘患者外周血中的CD+4 CD+25 T淋巴细胞的测定[J]. 中华结核和呼吸杂志, 2006, 29(4): 252-256
作者姓名:覃寿明  施焕中  覃雪军  陈一强  钟小宁
作者单位:530021,南宁,广西医科大学第一附属医院-广西医科大学呼吸疾病研究所
基金项目:国家自然科学基金资助项目(30460051);全国博士学位论文作者专项资金资助项目(200260)
摘    要:目的阐明支气管哮喘(简称哮喘)患者外周血中是否存訡D+4 CD+25 T调节性淋巴细胞,并探讨CD+4 CD+25细胞的免疫抑制活性.方法应用流式细胞仪检测29例过敏性哮喘患者[急性发作期患者(急性发作期)15例、缓解期患者(缓解期)14例和16名非过敏性健康志愿者(正常对照组)外周血中CD+4 CD+25 细胞数量变化.应用免疫磁珠法分离提纯CD+4 CD+25 细胞,将纯化的CD+4 CD+25细胞和(或)CD+4 CD-25细胞在体外培养,观察CD+4 CD-25细胞的增殖反应,将收集培养的上清液用酶联免疫吸附测定(ELISA)法检测Th1类细胞因子γ干扰素(IFN-γ)和Th2类细胞因子白细胞介素4(IL-4)和IL-13.结果急性发作期患者外周血中CD+4 CD+25细胞比值为(14.9±1.8)%,缓解期患者为(11.8±0.7)%,正常对照组为(11.2±0.8)%,发作期与缓解期患者比较差异有统计学意义(P<0.01);缓解期患者与正常对照组比较差异无统计学意义(P>0.05).哮喘组CD+4 CD-25细胞增殖反应为(74±9)%,正常对照组为(72±8)%,两组比较差异无统计学意义(P>0.05).此外,哮喘组和正常对照组的CD+4 CD+25 细胞均能抑制CD+4 CD-25细胞产生IFN-γ、IL-4和IL-13,而且两组的抑制能力也无明显区别.结论急性发作期哮喘患者外周血CD+4 CD+25 细胞数明显高于缓解期患者和正常对照组.哮喘患者的CD+4 CD+25 细胞的抑制活性和正常对照组比较差异无统计学意义.谮

关 键 词:CD4^+CD25^+细胞 淋巴细胞 病因学 哮喘
收稿时间:2005-06-07
修稿时间:2005-06-07

CD+4CD+25 T lymphocytes in peripheral blood from patients with asthma
QIN Shou-ming,SHI Huan-zhong,QIN Xue-jun,CHEN Yi-qiang,ZHONG Xiao-ning. CD+4CD+25 T lymphocytes in peripheral blood from patients with asthma[J]. Chinese journal of tuberculosis and respiratory diseases, 2006, 29(4): 252-256
Authors:QIN Shou-ming  SHI Huan-zhong  QIN Xue-jun  CHEN Yi-qiang  ZHONG Xiao-ning
Affiliation:Institute of Respiratory Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, China.
Abstract:OBJECTIVE: To explore whether regulatory CD(4)(+)CD(25)(+) cells exist in patients with atopic asthma. METHODS: The numbers of peripheral blood CD(4)(+)CD(25)(+) cells in peripheral blood of atopic asthmatics and healthy nonatopic subjects were determined using flow cytometry. CD(4)(+)CD(25)(+) and CD(4)(+)CD(25)(-) cells from atopic asthmatics and normal donors were isolated, and were cultured to observe the effects of CD(4)(+)CD(25)(+) cells on proliferation response as well as Th1/Th2 cytokine production of CD(4)(+)CD(25)(-) cells in vitro. RESULTS: A significant increase in CD(4)(+)CD(25)(+) cell numbers was shown in atopic asthmatic patients during acute exacerbation [(14.9 +/- 1.8)%, P < 0.01], but not in patients with stable asthma [(11.8 +/- 0.7)%] and normal subjects [(11.2 +/- 0.8)%, P > 0.05]. The mean inhibition values of the proliferation response of CD(4)(+)CD(25)(-) cells by CD(4)(+)CD(25)(+) cells from normal controls [(72 +/- 8)%] and asthmatics [(74 +/- 9)%] were similar (P > 0.05). There was no difference in inhibitory effects on both Th1 and Th2 cytokine production of CD(4)(+)CD(25)(-) cells by CD(4)(+)CD(25)(+) cells in the two groups. CONCLUSION: Although CD(4)(+)CD(25)(+) cells increase in atopic asthma during exacerbation, these regulatory T cells appear to function normally with regard to their suppressive activities.
Keywords:CD_4~+ CD_(25)~+ cells  Lymphocytes  Etiology  Asthma
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号